322 related articles for article (PubMed ID: 1940348)
1. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
Wallen N; Kita H; Weiler D; Gleich GJ
J Immunol; 1991 Nov; 147(10):3490-5. PubMed ID: 1940348
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils.
Hallsworth MP; Litchfield TM; Lee TH
Immunology; 1992 Feb; 75(2):382-5. PubMed ID: 1551701
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor.
Lamas AM; Leon OG; Schleimer RP
J Immunol; 1991 Jul; 147(1):254-9. PubMed ID: 2051022
[TBL] [Abstract][Full Text] [Related]
4. [Dexamethasone inhibits IL-5-induced eosinophil survival].
Sun Q; Zhu Y; Xu W; Zeng X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):43-6. PubMed ID: 12569639
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of TGF-beta 1 on cytokine-enhanced eosinophil survival].
Atsuta J; Fujisawa T; Iguchi K; Terada A
Arerugi; 1994 Sep; 43(9):1194-200. PubMed ID: 7802604
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils.
Okada S; Hagan JB; Kato M; Bankers-Fulbright JL; Hunt LW; Gleich GJ; Kita H
J Immunol; 1998 Apr; 160(8):4010-7. PubMed ID: 9558110
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effect of cytokines on eosinophil degranulation.
Fujisawa T; Abu-Ghazaleh R; Kita H; Sanderson CJ; Gleich GJ
J Immunol; 1990 Jan; 144(2):642-6. PubMed ID: 2104901
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.
Sedgwick JB; Busse WW
Ann Allergy Asthma Immunol; 1997 Jun; 78(6):581-5. PubMed ID: 9207722
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids.
Schleimer RP; Derse CP; Friedman B; Gillis S; Plaut M; Lichtenstein LM; MacGlashan DW
J Immunol; 1989 Aug; 143(4):1310-7. PubMed ID: 2473127
[TBL] [Abstract][Full Text] [Related]
11. Induction by interferons of human eosinophil apoptosis and regulation by interleukin-3, granulocyte/macrophage-colony stimulating factor and interleukin-5.
Morita M; Lamkhioued B; Soussi Gounni A; Aldebert D; Delaporte E; Capron A; Capron M
Eur Cytokine Netw; 1996 Dec; 7(4):725-32. PubMed ID: 9010674
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
Hartnell A; Kay AB; Wardlaw AJ
Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
[TBL] [Abstract][Full Text] [Related]
13. Delayed eosinophil apoptosis in asthma.
Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
[TBL] [Abstract][Full Text] [Related]
14. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium.
Her E; Frazer J; Austen KF; Owen WF
J Clin Invest; 1991 Dec; 88(6):1982-7. PubMed ID: 1752957
[TBL] [Abstract][Full Text] [Related]
15. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor.
Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y
J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160
[TBL] [Abstract][Full Text] [Related]
16. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.
Hagan JB; Kita H; Gleich GJ
Clin Exp Allergy; 1998 Aug; 28(8):999-1006. PubMed ID: 9756205
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 activates human peripheral blood eosinophils.
Hoenstein R; Admon D; Solomon A; Norris A; Moqbel R; Levi-Schaffer F
Cell Immunol; 2001 Jun; 210(2):116-24. PubMed ID: 11520078
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids inhibit chemokine generation by human eosinophils.
Miyamasu M; Misaki Y; Izumi S; Takaishi T; Morita Y; Nakamura H; Matsushima K; Kasahara T; Hirai K
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):75-83. PubMed ID: 9449504
[TBL] [Abstract][Full Text] [Related]
20. Effects of IFN on human eosinophils in comparison with other cytokines. A novel class of eosinophil activators with delayed onset of action.
Valerius T; Repp R; Kalden JR; Platzer E
J Immunol; 1990 Nov; 145(9):2950-8. PubMed ID: 1698867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
